InvestLog
← Back to Research← 返回研究
CTASEarnings ReleaseSource checkedJuly 15, 2026by InvestLog AI

CTAS earnings release — EPS beat +1.6% · revenue beat +1.2% · gross margin 51.0% · operating margin 23.2%信达思公司 (CTAS) 财报发布 — EPS 高于预期+1.6% · 营收 高于预期+1.2% · 毛利率 51.0% · 经营利润率 23.2%

Earnings Release Event

Cintas Corporation (CTAS) published results. Official release title: Cintas Corporation Announces Fiscal 2026 Fourth Quarter and Full Year Results; published at: 2026-07-15 08:30:00.

Actual vs Consensus

  • EPS: $1.26 vs $1.24 estimate, beat+1.6%.
  • Revenue: $2.9B vs $2.9B estimate, beat+1.2%.

    • Financial Quality Snapshot

  • Period: 2026 Q4 period ended 2026-05-31
  • Revenue: $2.9B; Revenue growth: +2.2%
  • Gross profit: $1.5B; Gross margin: 51.0%
  • Operating income: $673M; Operating margin: 23.2%
  • Net income: $511M; GAAP diluted EPS: $1.26
  • Operating cash flow: $709M; Capex: -$96M; Free cash flow: $613M; cash-flow status: available
  • Cash: $289M; Total debt: $2.7B; Net debt: $2.4B

    • 财报发布事件

    信达思公司 (CTAS) 已发布财报。官方发布标题：Cintas Corporation Announces Fiscal 2026 Fourth Quarter and Full Year Results；发布时间：2026-07-15 08:30:00。

    Actual vs Consensus

  • EPS：$1.26 vs $1.24 预期，高于预期+1.6%。
  • 营收：$2.9B vs $2.9B 预期，高于预期+1.2%。

    • 财务质量快照

  • 期间：2026 Q4 period ended 2026-05-31
  • 营收：$2.9B；营收增长：+2.2%
  • 毛利润：$1.5B；毛利率：51.0%
  • 经营利润：$673M；经营利润率：23.2%
  • 净利润：$511M；GAAP 稀释 EPS：$1.26
  • 经营现金流：$709M；资本开支：-$96M；自由现金流：$613M；现金流状态：available
  • 现金：$289M；总债务：$2.7B；净债务：$2.4B
    • View CTAS stock details ->查看 CTAS 个股详情 ->

    This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。

    Related research相关阅读

    CTAS earnings analysis — 8-K, statement tables信达思公司 (CTAS) 财报解读 — 8-K、statement tables

    Earnings Analysis · July 15, 2026

    CINTAS CORP files 8-K FDA regulatory update信达思公司 (CTAS) 提交 FDA 相关 8-K 披露

    SEC Material Disclosure · June 12, 2026